Equine Diagnostic Services Market: Market Size & Forecast 2026

The global equine diagnostic services market encompasses laboratory testing, imaging services, and point-of-care diagnostics specifically designed for horses. Valued at approximately $0.91 billion in 2025, the market represents a specialized segment within the broader veterinary diagnostics industry, which ranges from $3.7 billion to $16 billion in size depending on definition and scope. The market has evolved significantly from basic clinical pathology to include sophisticated imaging modalities and molecular diagnostic techniques.

• •Market valued at approximately $0.91 billion globally in 2025
• •Projected annual growth rate of 7.2%
• •Includes imaging, laboratory testing, and point-of-care diagnostics for equine patients

Technological integration serves as the primary catalyst for market expansion, with equine veterinary practices increasingly adopting digital radiography, ultrasonography, and advanced laboratory equipment. The growing companion animal trend has elevated horses from purely agricultural assets to performance and companion animals, justifying higher investment in healthcare. Additionally, rising awareness of preventive medicine and early disease detection has increased demand for routine diagnostic screening among equine owners.

• •Adoption of advanced imaging and molecular diagnostic technologies
• •Increasing recognition of horses as performance and companion animals driving healthcare spending
• •Growing emphasis on preventive care and early disease detection

The market spans various service types including imaging services, clinical pathology, molecular diagnostics, and point-of-care testing, with imaging representing a significant portion valued at $880 million to $934 million in 2025. Geographically, North America leads adoption, with the United States projected to grow at 5.9% annually through the forecast period, while Europe shows steady expansion with the United Kingdom at 5.2% CAGR. Developing equine markets in Asia-Pacific and Latin America are emerging as growth areas as veterinary infrastructure improves.

• •United States expected to grow at 5.9% CAGR from 2025
• •United Kingdom projected at 5.2% CAGR over the forecast period
• •Imaging services segment alone valued between $880 million and $934 million in 2025

What are the recent trends and outlook?

The market is shifting toward precision medicine and predictive health management, with telemedicine and remote diagnostic capabilities emerging as transformative technologies. Advances in genomics and biomarkers are enabling earlier disease detection and personalized treatment protocols for equine patients. Over the forecast horizon, the market is expected to maintain strong growth momentum, potentially reaching between $1.7 billion and $2.8 billion by 2030-2034 as technological advances reduce costs and expand accessibility of sophisticated diagnostic services.

• •Growing adoption of telemedicine and remote diagnostic technologies in equine care
• •Advances in genomics enabling precision medicine approaches for horses
• •Market projected to reach between $1.7 billion and $2.8 billion by 2030-2034 depending on scope